3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
20
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
2
Retinoblastoma
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Uterine Cervical Neoplasms
1
Sjogren's Syndrome
1
Scleroderma, Systemic
1
Retinal Neoplasms
1
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
1
Recurrence
1
Psoriasis
1
Ovarian Neoplasms
1
Ovarian Cancer Recurrent
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Multiple Sclerosis
1
Melanoma
1
Lymphatic Metastasis
1
Lupus Erythematosus, Systemic
1
Inflammatory Bowel Diseases
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Dermatomyositis
1
Crohn Disease
1
Colorectal Neoplasms
1
Interventions
pembrolizumab
1
osimertinib
1
durvalumab
1
AZD 6244
1
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Non Small Cell Lung Cancer
×
Platinum Compounds
×
1 year
×
Clear all
No trials found.